Book Value per Share: revbiosciences.com (REVB)

Graphic logo of Revelation Biosciences (REVB)

Revelation Biosciences currently lacks consistent profits, as its stability depends on clinical trial outcomes. The BVPS metric visualizes this process, where the value 18.04 serves as the baseline indicator of current value. The solution will be the commercialization of products to grow margins, while the foundation will be the Gemini ecosystem, which unites scientific institutes around proprietary molecules.

Revelation Biosciences Inc (REVB): Share Book Value from 07/04/2022 to 10/27/2026

revbiosciences.com - analytical breakdowns and key metrics (REVB)

- price and consensus price forecast:
Stock Quotes Revelation Bio|REVB - Price Target Chart
- market capitalization data:
Market Capitalization Revelation Biosciences, Inc.|REVB - Total Company Value
- book capitalization data:
Net Assets per Single Share Revelation Biosciences|REVB - Net Asset Value|Market Capitalization to Book Value Ratio revbiosciences.com|REVB - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Revelation Biosciences|REVB - Long-Term Debt to Capital|Short-Term Debt to Equity Revelation Biosciences, Inc.|REVB - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Revelation Biosciences, Inc.
Fundamental company valuation:Revelation Bio - REVB
Manufactured products of Revelation Biosciences, Inc.

For the biopharmaceutical business of Revelation Biosciences (REVB), which is developing the Gemini platform to combat sepsis, BVPS dynamics serve as an indicator of the company's material base preservation. This metric is calculated as the difference between all assets and liabilities divided by the number of shares, allowing an investor to assess the real value of ownership and the enterprise's level of capital protection in the absence of operating profit.

Competitors of Revelation Biosciences (REVB)

ARGX - Accounting Value per Share|BNTX - Net Assets per Single Share|Abivax Corp (ABVX) - Book Value per Share|ADMA (admabiologics.com) - Net Assets per Single Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|AnaptysBio Inc - Net Asset Value per Share|Net Assets per Single Share Astria Pharma (ATXS)|ENGN - Accounting Value of a Share|Book Value per Share RAPT|Net Asset Value per Share Aerovate Therapeutics|Accounting Value per Share Aclaris Therapeutics, Inc.|Net Assets per Single Share Kyverna Therapeutics Inc.|Tiziana Life Sciences PLC - Book Value per Share|Net Asset Value per Share CABA (Cabaletta Bio Inc)|Net Assets per Single Share Ventyx Biosciences VTYX|Net Assets per Single Share theratech.com THTX|Avalo Therapeutics - Book Value per Share|Eledon Pharmaceuticals Inc. (ELDN) - Book Value per Share|AGEN - Accounting Value per Share|Climb Bio, Inc (CLYM) - Book Price of a Share|ZURA: Book Value per Share|Net Assets per Share ATYR|Adagene - Net Assets per Single Share|Net Asset Value per Share IMA (ikenaoncology.com)|STTK - Net Assets per Single Share|EQ - Equity per Share|Accounting Value per Share Connect Pharma (CNTB)|IMUX - Accounting Value of a Share|atarabio.com (ATRA) - Book Value per Share|InflaRx (IFRX) - Net Assets per Single Share|XFOR: Book Value per Share|Net Assets per Share ACET|Celularity Inc. - Net Assets per Single Share|Net Asset Value per Share INMB (inmunebio.com)|Net Assets per Single Share BRNS|Net Assets per Share Kezar Life Sciences Inc. KZR|SABS: Book Value per Share|AKTX - Accounting Value per Share|enlivex.com - Book Value per Share|Q32 Bio (QTTB) - Net Assets per Share|Book Value per Share GOVX (GeoVax)|Net Asset Value per Share EDSA|Net Assets per Single Share iBio Corp IBIO|Equity per Share carismatx.com (CARM)|XTL Biopharmaceuticals - Book Value per Share|Accounting Value per Share Bolt Biotherapeutics Inc. BOLT|HCWB (HCW Biologics Inc) - Book Value per Share|APVO: Net Asset Value per Share|AIM ImmunoTech - Net Assets per Single Share|ADTX (Aditxt, Inc.) - Net Assets per Share|GRI - Net Assets per Single Share|Accounting Value of a Share xortx.com|Vyome Holdings - Book Value per Share|Net Asset Value per Share Indaptus Therapeutics Inc INDP|Accounting Value per Share Scinai SCNI|Net Assets per Single Share CalciMedica Inc CALI|AFMD - Book Value per Share|ALLK: Net Assets per Single Share|Net Assets per Single Share hookipapharma.com (HOOK)|IGM Biosciences (IGMS) - Share Book Value|ITOS - Book Value per Share|Accounting Value of a Share Ocean Biomedical Corp|Book Value per Share TCBP|Book Value per Share THRD (thirdharmonicbio.com)